SK defeats Pfizer in Korean patent feud, opening new lines of business for pneumococcal vaccine

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer. | The Supreme Court of Korea has sided with SK in an ongoing patent feud with Pfizer, ruling that the Korean company did not violate a composition patent on Pfizer’s pneumococcal shot Prevnar 13 by shipping components and finished research doses of its own 13-valent immunization, PCV13, to Russia.Read More